Skip to main content

Musculoskeletal Disorder

0
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Arctic Therapeutics
Arctic TherapeuticsIceland - Reykjavik
2 programs
NSAC - rapidN/A1 trial
NSAC health onlyN/A1 trial
Active Trials
NCT05310695Active Not Recruiting2,500Est. Oct 2034
NCT05006976Active Not Recruiting1,180Est. Jan 2033
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Electrical stimulation and biofeedback with Phenix Liberty medical deviceN/A1 trial
Active Trials
NCT05926739Completed27Est. Dec 2024
Physical Sciences
Physical SciencesMA - Andover
1 program
Massage sessionN/A1 trial
Active Trials
NCT06082752Completed80Est. Nov 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Human BioSciencesElectrical stimulation and biofeedback with Phenix Liberty medical device
Physical SciencesMassage session
Arctic TherapeuticsNSAC - rapid
Arctic TherapeuticsNSAC health only

Clinical Trials (4)

Total enrollment: 3,787 patients across 4 trials

NCT05926739Human BioSciencesElectrical stimulation and biofeedback with Phenix Liberty medical device

Performance and Safety of the PHENIX LIBERTY, a Medical Device for Electrostimulation and Biofeedback, in the Treatment of Musculoskeletal Disorders

Start: Aug 2024Est. completion: Dec 202427 patients
N/ACompleted
NCT06082752Physical SciencesMassage session

The Analysis of the Impact of 5-minute Massage Session on the Muscle Stiffness and Tone

Start: Oct 2023Est. completion: Nov 202380 patients
N/ACompleted
NCT05310695Arctic TherapeuticsNSAC - rapid

A Naturalistic Trial of the Norwegian Sickness Absence Clinic. The NSAC Efficacy Study

Start: Jan 2023Est. completion: Oct 20342,500 patients
N/AActive Not Recruiting
NCT05006976Arctic TherapeuticsNSAC health only

A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study

Start: Sep 2021Est. completion: Jan 20331,180 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.